Literature DB >> 17912578

Disease activity in longstanding ankylosing spondylitis: a correlation of clinical and magnetic resonance imaging findings.

L Goh1, P Suresh, A Gafoor, P Hughes, P Hickling.   

Abstract

We evaluated magnetic resonance imaging (MRI) changes in ankylosing spondylitis (AS) patients with longstanding disease and investigated whether there is any relationship between MRI findings and validated methods of disease assessment. A total of 34 AS patients with disease duration greater than 10 years were included in this observational cross-sectional study (26 men, 8 women). The main outcome measures were Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Global assessment (BASG), Bath Ankylosing Spondylitis Metrology Index (BASMI), MRI of the thoracic and lumbar spine (AS spi MRI A) and measurement of serum erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), plasma viscosity (PV) and immunoglobulin A (Ig A). The median scores for the acute lesions based on AS spi MRI A scoring system was 2.5 (0-4.12). The respective mean ESR and CRP were 36 (SD, 24.00) mm/h and 14.19 (SD, 24.00) mg/l with the median PV of 1.8 (1.75-1.87). The median BASG, BASFI and BASDAI were 4.55 (2.37-5.55), 4.40(2.31-5.47) and 4.32 (3.07-6.48), respectively. No significant correlations were found between the acute MRI scores and each of the clinical instruments and laboratory markers of inflammation. In this study, majority of AS patients with longstanding disease had very low AS spi MRI A scores or no evidence of spinal inflammatory lesions. Our study would suggest that MRI should be used along with other measures of disease activity in the assessment of symptomatic AS patients with longstanding disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17912578     DOI: 10.1007/s10067-007-0726-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  34 in total

1.  Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems.

Authors:  J Braun; X Baraliakos; W Golder; K-G Hermann; J Listing; J Brandt; M Rudwaleit; S Zuehlsdorf; M Bollow; J Sieper; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2004-04-05       Impact factor: 19.103

Review 2.  Imaging in ankylosing spondylitis.

Authors:  Walter P Maksymowych; Robert Landewé
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-06       Impact factor: 4.098

3.  Outcome assessment in clinical trials of ankylosing spondylitis.

Authors:  A S Rigby; A J Silman
Journal:  Br J Rheumatol       Date:  1991-10

4.  Discovertebral destruction in ankylosing spondylitis: the role of computed tomography and magnetic resonance imaging.

Authors:  J B Kenny; P L Hughes; G H Whitehouse
Journal:  Br J Radiol       Date:  1990-06       Impact factor: 3.039

5.  Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data.

Authors:  X Baraliakos; J Brandt; J Listing; H Haibel; H Sörensen; M Rudwaleit; J Sieper; J Braun
Journal:  Arthritis Rheum       Date:  2005-12-15

6.  The natural history of ankylosing spondylitis. Does it burn out?

Authors:  L G Kennedy; L Edmunds; A Calin
Journal:  J Rheumatol       Date:  1993-04       Impact factor: 4.666

7.  Is there a preferred method for scoring activity of the spine by magnetic resonance imaging in ankylosing spondylitis?

Authors:  Désirée van der Heijde; Robert Landewé; Kay-Geert Hermann; Martin Rudwaleit; Mikkel Østergaard; Ans Oostveen; Phil O'Connor; Walter P Maksymowych; Robert G Lambert; Cédric Lukas; Anne Grethe Jurik; Maarten Boers; Xenofon Baraliakos; Jürgen Braun
Journal:  J Rheumatol       Date:  2007-04       Impact factor: 4.666

8.  The relationship of clinical and laboratory measurements to radiological change in ankylosing spondylitis.

Authors:  H G Taylor; T Wardle; E J Beswick; P T Dawes
Journal:  Br J Rheumatol       Date:  1991-10

9.  The natural history of ankylosing spondylitis as defined by radiological progression.

Authors:  Sinead Brophy; Kirsten Mackay; Ahmed Al-Saidi; Gordon Taylor; Andrei Calin
Journal:  J Rheumatol       Date:  2002-06       Impact factor: 4.666

10.  Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis.

Authors:  Heiner Appel; Christoph Loddenkemper; Zarko Grozdanovic; Harald Ebhardt; Marc Dreimann; Axel Hempfing; Harald Stein; Peter Metz-Stavenhagen; Martin Rudwaleit; Joachim Sieper
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

View more
  9 in total

Review 1.  A systematic MEDLINE analysis of therapeutic approaches in ankylosing spondylitis.

Authors:  L Goh; A Samanta
Journal:  Rheumatol Int       Date:  2009-06-28       Impact factor: 2.631

2.  Correlation between clinical and MRI disease activity scores in axial spondyloarthritis.

Authors:  James W MacKay; Sharief Aboelmagd; J Karl Gaffney
Journal:  Clin Rheumatol       Date:  2015-04-19       Impact factor: 2.980

3.  Role of matrix metalloproteinase-3 (MMP-3) and magnetic resonance imaging of sacroiliitis in assessing disease activity in ankylosing spondylitis.

Authors:  Eiman Soliman; W Labib; G el-Tantawi; A Hamimy; A Alhadidy; A Aldawoudy
Journal:  Rheumatol Int       Date:  2011-03-24       Impact factor: 2.631

4.  Value of DWI in visual assessment of activity of sacroiliitis in longstanding ankylosing spondylitis patients.

Authors:  Hatice Tuba Sanal; Sedat Yilmaz; Umut Kalyoncu; Muhammet Cinar; Ismail Simsek; Hakan Erdem; Salih Pay; Ayhan Dinc; Cem Tayfun
Journal:  Skeletal Radiol       Date:  2012-06-28       Impact factor: 2.199

5.  Bone formation rather than inflammation reflects ankylosing spondylitis activity on PET-CT: a pilot study.

Authors:  Stefan T G Bruijnen; Mignon A C van der Weijden; Joannes P Klein; Otto S Hoekstra; Ronald Boellaard; J Christiaan van Denderen; Ben A C Dijkmans; Alexandre E Voskuyl; Irene E van der Horst-Bruinsma; Conny J van der Laken
Journal:  Arthritis Res Ther       Date:  2012-04-02       Impact factor: 5.156

6.  Down-Regulation of lncRNA-AK001085 and its Influences on the Diagnosis of Ankylosing Spondylitis.

Authors:  Xiang Li; Wei Chai; Guoqiang Zhang; Ming Ni; Jiying Chen; Jiyuan Dong; Yonggang Zhou; Libo Hao; Yang Bai; Yan Wang
Journal:  Med Sci Monit       Date:  2017-01-02

7.  Is There a Correlation Between Patient-Reported Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Score and MRI Findings in Axial Spondyloarthropathy in Routine Clinical Practice?

Authors:  Swetha Byravan; Nibha Jain; Jenna Stairs; Winston Rennie; Arumugam Moorthy
Journal:  Cureus       Date:  2021-11-16

8.  MRI bone oedema scores are higher in the arthritis mutilans form of psoriatic arthritis and correlate with high radiographic scores for joint damage.

Authors:  Yu M Tan; Mikkel Østergaard; Anthony Doyle; Nicola Dalbeth; Maria Lobo; Quentin Reeves; Elizabeth Robinson; William J Taylor; Peter B Jones; Karen Pui; Jamie Lee; Fiona M McQueen
Journal:  Arthritis Res Ther       Date:  2009-01-06       Impact factor: 5.156

9.  Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients.

Authors:  Walter P Maksymowych; Désirée van der Heijde; Xenofon Baraliakos; Atul Deodhar; Sarah P Sherlock; David Li; Dona Fleishaker; Thijs Hendrikx; Keith S Kanik
Journal:  Rheumatology (Oxford)       Date:  2018-08-01       Impact factor: 7.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.